Stock Alert: Chiasma Up 8% On Positive Results From Acromegaly Treatment Trial

Shares of Chiasma, Inc. (CHMA) gained over 8% on Wednesday morning after reporting positive results from a late-stage trial of treatment for Acromegaly.

CHMA is currently trading at $4.37, up $0.33 or 8.17%, on the Nasdaq.

Chiasma, a biopharmaceutical company developing oral therapies for rare diseases, announced positive top-line data from its global Phase 3 non-inferiority clinical trial comparing Mycapssa to long-acting injectable somatostatin analogs in patients with acromegaly.

The study met its primary non-inferiority endpoint. 91% of patients on Mycapssa maintained insulin-like growth factor 1 response compared to compared to 100% on injectable SSAs.

The trial was designed to support a planned marketing authorization application for Mycapssa in the European Union.

Mycapssa is currently approved in the United States for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with injectable octreotide or lanreotide.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Chinese e-commerce giant Alibaba Group Holdings Ltd. (BABA) reported Thursday a net loss for the fourth quarter that sharply widened from last year, despite 9 percent growth in revenues, hurt by a decreases in the market prices of our equity investments in publicly-traded companies. Omni-channel fashion retailer Macy's, Inc. (M) reported Thursday a first-quarter net income of $286 million or $0.98 per share, sharply higher than $103 million or $0.32 per share in the prior-year quarter. Excluding items, adjusted net income for the quarter was $315 million or $1.08 per share, compared... Richmond, Utah-based Casper's Ice Cream is recalling its 56 ounce tubs of "Red Button Vintage Creamery Canadian Vanilla Ice Cream" due to undeclared allergen, the U.S. Food and Drug Administration said. According to the agency, a limited number of the product were mispackaged with Burnt Almond Fudge Ice Cream containing undeclared almonds.
Follow RTT